Global Subcutaneous Immunoglobulins Market Status and Outlook 2018-2025

July 2018 | 138 pages | ID: G4CAE102228EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Shire (Baxalta)
• Grifols
• CSL

Market by Type

• 10% Purity
• 20% Purity

Market by Application

• Primary Immunodeficiency
• Secondary Immunodeficiency
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Subcutaneous Immunoglobulins Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 10% Purity
  3.1.2 20% Purity
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Primary Immunodeficiency
  4.1.2 Secondary Immunodeficiency
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 10% Purity Production by Region
    6.1.1.2 20% Purity Production by Region
  6.1.2 Production by Application
    6.1.2.1 Primary Immunodeficiency Production by Region
    6.1.2.2 Secondary Immunodeficiency Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 10% Purity Demand by Region
    6.2.1.2 20% Purity Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Primary Immunodeficiency Demand by Region
    6.2.2.2 Secondary Immunodeficiency Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Shire (Baxalta)
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Grifols
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 CSL
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Subcutaneous Immunoglobulins Industry Dynamics & Regulations List
Table Global Subcutaneous Immunoglobulins Sales Revenue, Cost and Margin, 2015-2018E
Table Global Subcutaneous Immunoglobulins Market Status by Type 2015-2018E, in USD Million
Table Global Subcutaneous Immunoglobulins Market Status by Application 2015-2018E, in USD Million
Table Global Subcutaneous Immunoglobulins Market Status by Application 2015-2018E, in Volume
Table Global Subcutaneous Immunoglobulins Market by Region 2015-2018E, in USD Million
Table Global Subcutaneous Immunoglobulins Market Share by Region in 2018, in USD Million
Table Global Subcutaneous Immunoglobulins Market by Region 2015-2018E, in Volume
Table Global Subcutaneous Immunoglobulins Market Share by Region in 2018, in Volume
Table 10% Purity Production Value by Region 2015-2018E, in USD Million
Table 10% Purity Production Volume by Region 2015-2018E, in Volume
Table 20% Purity Production Value by Region 2015-2018E, in USD Million
Table 20% Purity Production Volume by Region 2015-2018E, in Volume
Table Primary Immunodeficiency Production Value by Region 2015-2018E, in USD Million
Table Primary Immunodeficiency Production Volume by Region 2015-2018E, in Volume
Table Secondary Immunodeficiency Production Value by Region 2015-2018E, in USD Million
Table Secondary Immunodeficiency Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table 10% Purity Market Size by Region 2015-2018E, in USD Million
Table 10% Purity Market Size by Region 2015-2018E, in Volume
Table 20% Purity Market Size by Region 2015-2018E, in USD Million
Table 20% Purity Market Size by Region 2015-2018E, in Volume
Table Primary Immunodeficiency Market Size by Region 2015-2018E, in USD Million
Table Primary Immunodeficiency Market Size by Region 2015-2018E, in Volume
Table Secondary Immunodeficiency Market Size by Region 2015-2018E, in USD Million
Table Secondary Immunodeficiency Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalSubcutaneous Immunoglobulins Forecast by Type 2019F-2025F, in USD Million
Table Subcutaneous Immunoglobulins Forecast by Type 2019F-2025F, in Volume
Table Subcutaneous Immunoglobulins Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Subcutaneous Immunoglobulins Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Subcutaneous Immunoglobulins Market Forecast by Region 2019F-2025F, in USD Million
Table Subcutaneous Immunoglobulins Market Forecast by Region 2019F-2025F, in Volume
Table Shire (Baxalta) Information
Table Subcutaneous Immunoglobulins Sales, Cost, Margin of Shire (Baxalta)
Table Grifols Information
Table Subcutaneous Immunoglobulins Sales, Cost, Margin of Grifols
Table CSL Information
Table Subcutaneous Immunoglobulins Sales, Cost, Margin of CSL
Table Global Subcutaneous Immunoglobulins Sales Revenue by Company 2015-2017, in USD Million
Table Global Subcutaneous Immunoglobulins Sales Volume by Company 2015-2017, in Volume
Table Global Subcutaneous Immunoglobulins Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Subcutaneous Immunoglobulins Picture
Figure Subcutaneous Immunoglobulins Industry Chain Diagram
Figure Global Subcutaneous Immunoglobulins Sales Revenue 2015-2018E, in USD Million
Figure Global Subcutaneous Immunoglobulins Sales Volume 2015-2018E, in Volume
Figure Global Subcutaneous Immunoglobulins Market Status by Type 2015-2018E, in Volume
Figure North America Subcutaneous Immunoglobulins Market Size and Growth 2015-2018E, in USD Million
Figure North America Subcutaneous Immunoglobulins Market Size and Growth 2015-2018E, in Volume
Figure Europe Subcutaneous Immunoglobulins Market Size and Growth 2015-2018E, in USD Million
Figure Europe Subcutaneous Immunoglobulins Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Subcutaneous Immunoglobulins Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Subcutaneous Immunoglobulins Market Size and Growth 2015-2018E, in Volume
Figure South America Subcutaneous Immunoglobulins Market Size and Growth 2015-2018E, in USD Million
Figure South America Subcutaneous Immunoglobulins Market Size and Growth 2015-2018E, in Volume
Figure Middle East Subcutaneous Immunoglobulins Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Subcutaneous Immunoglobulins Market Size and Growth 2015-2018E, in Volume
Figure Africa Subcutaneous Immunoglobulins Market Size and Growth 2015-2018E, in USD Million
Figure Africa Subcutaneous Immunoglobulins Market Size and Growth 2015-2018E, in Volume
Figure Global Subcutaneous Immunoglobulins Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Subcutaneous Immunoglobulins Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Subcutaneous Immunoglobulins Sales Price Forecast 2019F-2025F
Figure Global Subcutaneous Immunoglobulins Gross Margin Forecast 2019F-2025F
Figure Global Subcutaneous Immunoglobulins Sales Revenue by Company in 2018, in USD Million
Figure Global Subcutaneous Immunoglobulins Price by Company in 2018
Figure Global Subcutaneous Immunoglobulins Gross Margin by Company in 2018